HISTOGENESIS OF SOLID TYPE DUCT CANCER OF A WOMAN’S BREAST GLAND

Authors:

Abstract:

In Ukraine, the development of ductal cancer of the mammary gland continues to be a growing problem for the health of women, not only of the elderly but also of young age, and the cause of death in 18–20 % of cases. Non-invasive forms of cancer, which account for 5–8 % of cases, are associated with the proliferative process in the alveolar part of the gland. The structural and functional organization of the epithelium in the terminal duct of the gland on the autopsy material of women of reproductive age who died from infectious diseases was studied, as well as the solid type of ductal cancer of the gland was retrospectively identified, according to the WHO classification (2003); histological, histochemical, immunohistochemical methods were applied (markers p63, bcl-2, α-sma, VEGF from DakoCytomation) with karyometric analysis. The paper presents a new theoretical justification and solution to the topical issue of histogenesis of solid breast cancer based on a comparison with the epithelium of the terminal part of the duct – the acinus-button. The histogenesis of cancer with an extreme degree of cataplasia associated with the terminal part of the duct is presented.

Keywords:

histogenesis solid cancer mammary gland immunohistochemistry karyometry

References:

1. Bagriy MM, Dibrova VA, Popadynets OG, Hryshchuk MI. Metody morfolohichnoho doslidzhennya: monohrafiya. Vinnytsia: New book. 2016. 328 s. [in Ukrainian]
2. Vakhnyuk TV. Histolohiya z tekhnikoyu histolohichnykh doslidzhen. Kyiv: Medicine.2018. 256 s. [in Ukrainian]
3. Kumar V, Abbas AK, Aster D. Osnovy patolohiyi za Robbinsom. K.: VSV Medytsyna. 2019; 1–30. [in Ukrainian]
4. Baek ML, Lee J, Pendleton KE, Berner MJ, Goff EB, Tan L, et al. Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment. Oncogene. 2023 Mar;42(14):1117–1131. doi: 10.1038/s41388-023-02596-8.
5. Foschini MP, Nishimura R, Fabbri VP, Varga Z, Kaya H, Cserni G. Breast lesions with myoepithelial phenotype. Histopathology. 2023 Jan;82(1):53–69. doi: 10.1111/his.14826.
6. Franco PIR, Neto JRDC, de Menezes LB, Machado JR, Miguel MP. Revisiting the hallmarks of cancer: A new look at long noncoding RNAs in breast cancer. Pathol Res Pract. 2023 Mar;243:154381. doi: 10.1016/j.prp.2023.154381.
7. Liu H, Gruber CW, Alewood PF, Möller A, Muttenthaler M. The oxytocin receptor signalling system and breast cancer: a critical review. Oncogene. 2020 Sep;39(37):5917–5932. doi: 10.1038/s41388-020-01415-8.
8. Miao G, Zhuo D, Han X, Yao W, Liu C, Liu H, Cao H, Sun Y, Chen Z, Feng T. From degenerative disease to malignant tumors: Insight to the function of ApoE. Biomed Pharmacother. 2023 Feb;158:114127. doi: 10.1016/j.biopha.2022.114127.
9. Mihalcea CE, Moroşanu AM, Murăraşu D, Puiu L, Cinca SA, Voinea SC, et al. Analysis of TP53 gene and particular infrastructural alterations in invasive ductal mammary carcinoma. Rom J Morphol Embryol. 2020 Apr-Jun;61(2):441–447. doi: 10.47162/RJME.61.2.13.
10. Moreira MP, Brayner FA, Alves LC, Cassali GD, Silva LM. Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation. Eur Biophys J. 2019 Oct;48(7):673–684. doi: 10.1007/s00249-019-01393-0.
11. Nel J, Elkhoury K, Velot É, Bianchi A, Acherar S, Francius G, Tamayol A, Grandemange S, Arab-Tehrany E. Functionalized liposomes for targeted breast cancer drug delivery. Bioact Mater. 2023 Jan 2;24:401–437. doi: 10.1016/j.bioactmat.2022.12.027.
12. Osako T. How can we better distinguish metastatic tumors from primary tumors in the breast? Expert Rev Anticancer Ther. 2021 Sep;21(9):913–916. doi: 10.1080/14737140.2021.1944107.
13. Shams A. Re-evaluation of the myoepithelial cells roles in the breast cancer progression. Cancer Cell Int. 2022 Dec 12;22(1):403. doi: 10.1186/s12935-022-02829-y.
14. Tarin D. The Host Stroma and the Tumour Microenvironment. Understanding Cancer: The Molecular Mechanisms, Biology, Pathology and Clinical Implications of Malignant Neoplasia. Springer. 2023; 93-110. doi: 10.1007/978-3-030-97393-3.

Publication:

«World of Medicine and Biology» Vol. 20 No. 88 (2024) , с. 216-221
УДК 618.19-006-092-071

DOI:

https://doi.org/10.26724/2079-8334-2024-2-88-216-221